Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies

This study employs a multicenter, randomized, open-label, positive drug-controlled, multiple ascending dose clinical trial design to comprehensively evaluate the safety, tolerability, immunogenicity, and pharmacokinetic characteristics of SSS06 injection in patients with chemotherapy-induced anemia from non-myeloid malignancies, while also exploring its potential efficacy.

NCT Number	NCT06854276
Lead Sponsor	Shenyang Sunshine Pharmaceutical Co., LTD.
Conditions	Chemotherapy-induced Anemia, Non-myeloid Malignancies
Enrollment	80 participants
Start Date	2025-03-01
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-03-03